The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AURA BIOSCIENCES INC COM 05153U107 21,583,233 3,039,892 SH SOLE 1 3,039,892 0 0
NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES N62509109 74,850,776 2,208,639 SH SOLE 1 2,208,639 0 0
PHATHOM PHARMACEUTICALS INC COM 71722W107 80,990,606 7,464,572 SH SOLE 1 7,464,572 0 0